Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FATYZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,234
Award facts
- Contract value 100% obligated
- $5,234.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,234.42 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Zepbound 2.5 mg/0.5 ml pen injections on October 24, 2025. The delivery order, which carries a firm fixed-price structure with no set-aside designation, is scheduled for completion by October 27, 2025, with performance taking place in Conshohocken, Pennsylvania. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, is a specialized federal pharmaceutical supplier that has maintained System for Award Management registration since 2001 and demonstrates consistent capability in delivering pharmaceutical products to Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) Indefinite Delivery Contract (SPE2DR), a single-award vehicle established under the Defense Logistics Agency's $30.3 billion PPV-G GEN V acquisition strategy. The underlying indefinite delivery contract, awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical supplier authorized to provide branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. The company has demonstrated substantial federal contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, with no subcontractor relationships identified in the award documentation.
Quick answers
Who was awarded contract SPE2DB26FATYZ?
SPE2DB26FATYZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FATYZ worth?
The government has obligated $5,234 on SPE2DB26FATYZ.
Is contract SPE2DB26FATYZ an order under another contract?
Yes. SPE2DB26FATYZ is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATYZ competed?
The extent of competition for SPE2DB26FATYZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award